GlassScriptPhysician profile
Henry B Boler
NPI 1578926663
$7,132.33
in general payments reported to CMS, 2019-2025
34 companies · $1,474 in 2025
The $1,474 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $202 · 2020: $373 · 2021: $1,334 · 2022: $928 · 2023: $861 · 2024: $1,960 · 2025: $1,474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,426 · Travel and Lodging: $868.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,426.05 |
| Travel and Lodging | $868.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Imaging Healthcare North America LLC | $863.09 | 2024 | Umi 550, Umi 550 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $617.26 | 2021-2022 | |
| Pfizer INC. | $552.63 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $524.73 | 2021-2025 | Verquvo, Capvaxive |
| Astrazeneca Pharmaceuticals LP | $442.35 | 2019-2023 | Brilinta |
| Penumbra, INC. | $435.47 | 2022-2025 | Indigo System |
| Boston Scientific Corporation | $434.74 | 2021-2025 | General - Vascular Intervention, Watchman Access System, Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $368.64 | 2021-2025 | Camzyos, Eliquis |
| Irhythm Technologies, INC. | $318.23 | 2021-2023 | Zio Xt Patch |
| Alnylam Pharmaceuticals INC. | $276.05 | 2023-2025 | Amvuttra, Onpattro |
| Siemens Medical Solutions USA, INC. | $267.48 | 2024-2025 | Magnetom Sola, Biograph Horizon-3r |
| Novartis Pharmaceuticals Corporation | $264.80 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $261.86 | 2020-2025 | Lifevest |
| Medtronic, INC. | $221.24 | 2024-2025 | Symplicity G3, Corevalve Evolut R, Ffrangio |
| Janssen Pharmaceuticals, INC | $187.42 | 2019-2024 | Xarelto |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $128.24 | 2023 | |
| Philips North America LLC | $125.00 | 2021 | |
| Amgen INC. | $124.81 | 2020-2025 | Repatha |
| Impulse Dynamics (USA) INC. | $119.07 | 2022-2023 | Optimizer |
| Abiomed | $99.99 | 2024-2025 | Impella |
| Esperion Therapeutics, INC. | $85.53 | 2025 | Nexletol |
| Lexicon Pharmaceuticals, INC. | $82.31 | 2024 | |
| Thrombolex, INC. | $68.71 | 2025 | Bashir Endovascular Catheter |
| Actelion Pharmaceuticals US, INC. | $64.25 | 2022-2023 | Uptravi |
| Atricure, INC. | $41.98 | 2023 | |
| Abbott Laboratories | $24.22 | 2022 | |
| Daiichi Sankyo INC. | $22.61 | 2024 | Injectafer |
| Cardiva Medical, INC. | $21.05 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Livanova USA, INC. | $18.51 | 2022 | |
| Nuwellis, INC. | $15.78 | 2024 | Aquadex Smartflow Console |
| Cardiovascular Systems INC. | $15.08 | 2021 | |
| Lantheus Medical Imaging, INC. | $14.58 | 2024 | |
| Daxor Corporation | $13.55 | 2024 | Bva-100 |
| United Therapeutics Corporation | $11.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Boler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.